C Rustemeijer

Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?

C Rustemeijer, J. A. Schouten, H. J. Voerman et al. · Clinical Science · 2001 · 42 citations

Hyperlipidemia, Type Ii, Metabolic Syndrome +17

The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia

Nicoline Hoogerbrugge, M. J. T. M. MOL, J. J. VAN DORMAAL et al. · Journal of Internal Medicine · 1990 · 36 citations

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

C Rustemeijer, J. A. Schouten, H. J. Voerman et al. · Diabetes/Metabolism Research and Reviews · 2000 · 24 citations

Pravastatin in diabetes-associated hypercholesterolemia

C Rustemeijer, J. A. Schouten, E.N.W. Janssens et al. · Acta Diabetologica · 1997 · 16 citations

Metabolic Syndrome, Cardiovascular Disease, Diabetes +7

Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes

P Scheffer, M E Tushuizen, Hendrikus P.A. Vermue et al. · European Journal of Clinical Nutrition · 2011 · 10 citations · Full text